MedTrace Logo

Postoperative Analgesia With Local Infiltration After Hip Fracture Of Intertrochanteric Type

NCT01119209 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 74

Last updated 2011-03-16

No results posted yet for this study

Summary

Reducing pain is an essential factor for early mobilization after osteosynthesis of intertrochanteric fractures. Systemic opioids have side effects that might obstruct mobilization and induce delirium and nausea. The investigators hypothesized that wound infiltration results in reduction in systemic opioid usage and pain relief without side effects.

Conditions

  • Hip Fracture of Intertrochanteric Type

Interventions

DRUG

Ropivacaine

Approved by the Danish Medicines Agency

DRUG

Saline

Approved by the Danish Medicines Agency

Sponsors & Collaborators

  • Odense University Hospital

    lead OTHER

Principal Investigators

  • Soren Overgaard, MD, DmSc · Odense University Hospital, DK-5000 Odense C, Denmark

  • Rune Dueholm Bech, MD · Odense University Hospital, DK-5000 Odense C, Denmark

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-02-29
Primary Completion
2011-01-31
Completion
2011-01-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01119209 on ClinicalTrials.gov